eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-ALKS-Alkermes plc

Alkermes plc ALKS

$27.93-0.62(-2.18%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Alkermes plc
Today
Create an eToro account to buy ALKS stock on a secure, user-friendly, multi-asset trading platform.
Buy Alkermes plc
Buy Alkermes plc
Alkermes plc ALKS
Buy ALKS
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
42.43
Based on analysts who covered ALKS

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Alkermes plc News

More about Alkermes plc
Alkermes PLC is a fully-integrated biopharmaceutical company with international operations. The company researches, develops, and manufactures medicines to treat debilitating diseases such as those in the fields of oncology and neuroscience. Established in 1987, Alkermes is based in Dublin, Ireland.

Available on the NASDAQ GS stock exchange, the company is listed using the ALKS ticker. As of November 2020, this stock provided a -10.06% one-year return. The ALKS share price ranged from a 52-week high of $21.86 in December 2019 before falling to a 52-week low of $11.98 in March 2020. In November 2020, this stock was trading at $18.50.

Alkermes has numerous product candidates in development, including those to treat cancer, neurodegenerative disorders, schizophrenia, and bipolar I disorder. Additionally, the company has several products that are already on the market, including Aristada to treat schizophrenia, Vivitrol to treat alcohol and opioid dependence, Risperdal Consta to treat schizophrenia and bipolar I disorder, and a number of other medications. Alkermes has a collaboration agreement with Janssen Pharmaceutica, a license agreement with Acorda Therapeutics, Inc., and both types of agreements with Biogen Swiss Manufacturing GmbH.

Make ALKS stock an addition to your eToro watchlist to start receiving the latest news and updates.
VIEW MORE   

ALKS Stock Price Chart

‎-1.70‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Alkermes plc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Alkermes plc price today is $27.93, a ‎-2.18‎% change in the last 24 hours and ‎3.08‎% in the past week. Alkermes plc price changed by ‎-2.70‎% in the past year.
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
-
Day’s Range
i
Shows the high and low prices of the day.
$27.66 - $28.36
52W Range
i
Shows the high and low prices of the last year.
$22.87 - $36.35
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
-
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-
Revenue
i
The total income generated by this company’s goods and services last year.
-
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
-
Prev Close
i
The final price of this asset at the end of the last trading day.
$28.55
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
-
What Is Alkermes plc?
Alkermes PLC is a fully-integrated biopharmaceutical company with international operations. The company researches, develops, and manufactures medicines to treat debilitating diseases such as those in the fields of oncology and neuroscience. Established in 1987, Alkermes is based in Dublin, Ireland.

Available on the NASDAQ GS stock exchange, the company is listed using the ALKS ticker. As of November 2020, this stock provided a -10.06% one-year return. The ALKS share price ranged from a 52-week high of $21.86 in December 2019 before falling to a 52-week low of $11.98 in March 2020. In November 2020, this stock was trading at $18.50.

Alkermes has numerous product candidates in development, including those to treat cancer, neurodegenerative disorders, schizophrenia, and bipolar I disorder. Additionally, the company has several products that are already on the market, including Aristada to treat schizophrenia, Vivitrol to treat alcohol and opioid dependence, Risperdal Consta to treat schizophrenia and bipolar I disorder, and a number of other medications. Alkermes has a collaboration agreement with Janssen Pharmaceutica, a license agreement with Acorda Therapeutics, Inc., and both types of agreements with Biogen Swiss Manufacturing GmbH.

Make ALKS stock an addition to your eToro watchlist to start receiving the latest news and updates.
Buy ALKS

How can I buy Alkermes plc stocks?

To purchase Alkermes plc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Alkermes plc (ALKS) page and place an order to buy Alkermes plc.
Buy ALKS
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Alkermes plc
Invest in Alkermes plc
Today
Create an eToro account to buy ALKS stock on a secure, user-friendly, multi-asset trading platform.
Buy ALKS

FAQ

The current price of ALKS is $27.93.
The average price target for Alkermes plc is $42.43. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Alkermes plc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Alkermes plc is -
Based on 8 analysts offering recommendations for ALKS in the last 3 months, the overall consensus is Moderate Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top